Civica Interested In Retired Or Withdrawn ANDAs
Seeks Talks With Manufacturers Over 250 ANDAs For Essential Medicines
As a part of its strategy to develop its own ANDAs for essential medications, Civica has expressed interest in taking over existing ANDAs that are being retired or withdrawn by other generics manufacturers.